Curtis Holt

Bioscience Research — United States

Medicine · Health Sciences

27h-index4.4kcitations60works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis C virus research(22), Liver Disease and Transplantation(22), Renal Transplantation Outcomes and Treatments(21), Hepatitis B Virus Studies(19), Organ Transplantation Techniques and Outcomes(19)

Publications60 total

Safety and efficacy of tenofovir alafenamide in preventing hepatitis B virus recurrence after liver transplantation in patients with chronic kidney disease maintained on tenofovir disoproxil fumarate: Results from a phase 2 randomized trial
American Journal of Transplantation·2025
TRANSCEND: A Phase 3 Trial of the Anti-CD38 Antibody Felzartamab in Kidney Transplant Recipients with Late Antibody-Mediated Rejection
American Journal of Transplantation·2025
Evaluation of renal and bone safety at 4 years in post-liver transplant patients with chronic kidney disease receiving Tenofovir Alafenamide for HBV prophylaxis
Journal of Hepatology·2022
Overview of Immunosuppressive Therapy in Solid Organ Transplantation
Anesthesiology Clinics·2017· 111 cited
A Randomized, Prospective, Pilot Study of Tacrolimus-Sparing Immunosuppression Induction with Basiliximab, in Patients Undergoing Orthotopic Liver Transplantation with Pre-Orthotopic Liver Transplantation Renal Dysfunction
Journal of the American College of Surgeons·2016· 1 cited
Paritaprevir/ritonavir/ombitasvir and dasabuvir for the treatment of chronic hepatitis C virus infection
Expert Opinion on Pharmacotherapy·2015· 12 cited
Infections After Transplantation
Elsevier eBooks·2015· 3 cited
Contributors
Elsevier eBooks·2015
Multicenter review of liver transplant for hepatitis B‐related liver disease: disparities in gender and ethnicity
Clinical Transplantation·2013· 12 cited
The Evolution of Liver Transplantation During 3 Decades
Annals of Surgery·2013· 194 cited
Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues
Liver Transplantation·2013· 30 cited
Liver Transplantation for Nonalcoholic Steatohepatitis
Annals of Surgery·2012· 227 cited
Posttransplantation Hepatitis B Prophylaxis with Combination Oral Nucleoside and Nucleotide Analog Therapy
American Journal of Transplantation·2011· 75 cited
Liver transplant: a primer.
PubMed·2010· 5 cited
Decision analysis model for hepatitis B prophylaxis one year after liver transplantation
Liver Transplantation·2009· 31 citedOpen Access
Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation
Therapeutic Drug Monitoring·2006· 328 cited
Mortality predictors in liver transplant recipients with recurrent hepatitis C cirrhosis
Liver International·2005· 25 cited
Analysis of Long-term Outcomes of 3200 Liver Transplantations Over Two Decades
Annals of Surgery·2005· 405 citedOpen Access
A Comparison of Tacrolimus and Cyclosporine in Liver Transplantation: Effects on Renal Function and Cardiovascular Risk Status
American Journal of Transplantation·2005· 90 citedOpen Access
MELD fails to measure quality of life in liver transplant candidates
Liver Transplantation·2005· 126 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Ronald W. Busuttil(33), Hasan Yersiz(18), Douglas G. Farmer(16), Sammy Saab(15), Paul Martin(12), Leonard I. Goldstein(11), Sue V. McDiarmid(8), Rafik M. Ghobrial(8), R. Mark Ghobrial(8), David K. Imagawa(7), Philip Seu(6), Francisco Durazo(6), Hugo R. Rosen(6), Leonard D. Goldstein(6), James F. Markmann(5), Jonathan R. Hiatt(5), Fady M. Kaldas(5), Theodore M. Sievers(5), Steven Han(4), Carlos Cao(4)